Previous close | 99.52 |
Open | 99.74 |
Bid | 99.26 x 1700 |
Ask | 99.78 x 1700 |
Day's range | 99.08 - 99.78 |
52-week range | 95.18 - 134.35 |
Volume | |
Avg. volume | 26 |
Market cap | 6.286B |
Beta (5Y monthly) | 0.62 |
PE ratio (TTM) | 22.08 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Jazz stock toppled Thursday — but shares of key rival Praxis surged — after its essential tremor drug failed in midstage testing.
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript May 1, 2024 Jazz Pharmaceuticals plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name is Krista, and I will be your conference operator today. […]